您的位置: 首页 > 农业专利 > 详情页

Cholesteryl Ester Transfer Protein (CETP) Inhibitor and Pharmaceutical Compositions Comprising Said Inhibitor for Use in the Treatment or Prevention of Cardiovascular Diseases
专利权人:
DEZIMA PHARMA B.V.;MITSUBISHI TANABE PHARMA CORPORATION
发明人:
John FORD,Patrick ROUND,John KASTELEIN,Atsuhiro KAWAGUCHI,Koichi TOMIYASU,Kozo OKA
申请号:
US16844996
公开号:
US20200230138A1
申请日:
2020.04.09
申请国别(地区):
US
年份:
2020
代理人:
摘要:
The present invention relates to a cholesteryl ester transfer protein (CETP) inhibitor for use in the treatment of subjects suffering from or having an increased risk for cardiovascular diseases, in particular hyperlipidemia or mixed dyslipidemia. A further aspect of the present invention relates to a pharmaceutical composition for use in the treatment of subjects suffering from or having an increased risk for cardiovascular diseases, wherein the composition comprises a therapeutically effective amount of said CETP inhibitor.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充